Kaiser Jamil

Jawaharlal Nehru Institute of Advanced Studies 
Cancer Biology, Biomorkers, Pharmacogenomics, genetics,
"Kaiser Jamil"
Mean distance: 106866
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Begam N, Jamil K, Raju SG. (2017) Promoter Hypermethylation of the ATM Gene as a Novel Biomarker for Breast Cancer Asian Pacific Journal of Cancer Prevention : Apjcp. 18: 3003-3009
Jamil K, Jayaraman A, Ahmad J, et al. (2017) TNF-alpha -308G/A and -238G/A polymorphisms and its protein network associated with type 2 diabetes mellitus. Saudi Journal of Biological Sciences. 24: 1195-1203
Madhukaran SP, Koippallil Gopalakrishnan AR, Pandit H, et al. (2016) Expression of surfactant proteins SP-A and SP-D in murine decidua and immunomodulatory effects on decidual macrophages. Immunobiology. 221: 377-86
Kakarala KK, Jamil K. (2016) Biased signaling: potential agonist and antagonist of PAR2. Journal of Biomolecular Structure & Dynamics. 34: 1363-76
Kamal N, Curtis S, Hasan MS, et al. (2016) Trends in equity in use of maternal health services in urban and rural Bangladesh International Journal For Equity in Health. 15
Jamil K, Ahmad SUI, Manzoor S. (2016) HIBRA: A computer code for heavy ion binary reaction analysis employing ion track detectors Computer Physics Communications. 198: 216-221
Lakkireddy S, Aula S, Kapley A, et al. (2016) Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome Molecular Diagnosis and Therapy. 20: 33-44
Sushma PS, Jamil K, Kumar PU, et al. (2015) PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine
Lakkireddy S, Aula S, Avn S, et al. (2015) Association of The Common CYP1A1*2C Variant (Ile462Val Polymorphism) with Chronic Myeloid Leukemia (CML) in Patients Undergoing Imatinib Therapy. Cell Journal. 17: 510-9
Jayaraman A, Jamil K, Khan HA. (2015) Identifying new targets in leukemogenesis using computational approaches. Saudi Journal of Biological Sciences. 22: 610-22
See more...